Samsrita Labs Stock Screener | Share Price & Fundamental Analysis

SAMSRITA Healthcare Service Provider
Share Price BSE
₹17.35
▲ 1.46 (9.19%)
2026-04-13 00:00:00
As of April 13, 2026, the Samsrita Labs share price (BSE: SAMSRITA) is ₹17.35, up 9.19% from the previous close, with shares trading between ₹14.31 and ₹17.47, and a 52-week range of ₹14.14–₹25.54. Browse SAMSRITA quarterly financials to support your investment research. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Samsrita Labs Market Cap ₹33.94 Cr.
SAMSRITA P/E Ratio (TTM) -
Samsrita Labs P/B Ratio 2.34
EPS (TTM) ₹-0.19
Dividend Yield -
Debt to Equity 0.19
SAMSRITA 52 Week High ₹25.54
Samsrita Labs 52 Week Low ₹14.14
Operating Margin -
Profit Margin -
SAMSRITA Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹16.00
Total Equity ₹12.00

Samsrita Labs Share Price History - Stock Screener Chart

Screen SAMSRITA historical share price movements with interactive charts. Analyze price trends and patterns.

Samsrita Labs Company Profile - Fundamental Screener

Screen Samsrita Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SAMSRITA shares.
Sector Healthcare Services
Industry Healthcare Service Provider
Sub-Sector Healthcare Service Provider
Segment E
ISIN INE579N01018

Samsrita Labs Balance Sheet Screener

Screen SAMSRITA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018 2017
Assets
Total Assets 16 16 16 17 17 28 26 23 19
Current Assets 6 6 6 7 7 7 6 4 3
Fixed Assets 0 0 0 0 0 0 0 0 1
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0 0
Current Liabilities 0 0 0 0 0 0 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 12 12 13 13 11 16 16 16 12
Share Capital 15 15 15 15 15 15 14 12 10
Reserves & Surplus -3 -3 -2 -2 -4 -3 -2 -2 -2

Samsrita Labs Income Statement Screener - Profit & Revenue Analysis

Screen Samsrita Labs income statement and profit fundamentals. Analyze SAMSRITA quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Samsrita Labs share price evaluation.
Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Dec 2021-Mar 2021-Jun 2021-Sept 2020-Mar 2020-Jun 2020-Sept 2020-Dec 2019-Mar 2019-Jun 2019-Sept
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0
Expenses 0 0 5 3 0 0 0 0 1 0 0 0 5 1 1
EBITDA 0 0 -5 -3 0 0 0 0 -1 0 0 0 -2 -1 -1
Operating Profit % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -221.00% -3100.00% 0.00% 0.00% -122.00% -164.00% -171.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 -5 -3 0 0 0 0 -1 0 0 0 -2 -1 -1
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 0 0 -5 -3 0 0 0 0 0 0 0 0 -2 -1 -1
EPS 0.00 0.00 -2.00 -1.29 0.00 0.09 -0.03 -0.02 -0.26 -0.19 -0.19 -0.13 0.00 -0.42 -0.36

Samsrita Labs Cash Flow Screener - Liquidity Fundamentals

Screen SAMSRITA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March
Operating Activities 0 0 1 0 0 -1 -3 -3 0
Investing Activities 0 0 0 0 0 -1 -2 -1 -1
Financing Activities 0 0 -1 0 1 2 4 5 1
Net Cash Flow 0 0 0 0 0 0 0 0 0

Samsrita Labs Shareholding Pattern Screener

See Samsrita Labs shareholding pattern with promoter, FII, and DII holdings. Check Samsrita Labs promoter holding and ownership changes for SAMSRITA on TickJournal.
Item 2025-Mar 2025-Jun 2025-Jul 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept
Promoter Holding 49.27% 48.25% 31.41% 31.41% 25.44% 52.87% 52.87% 52.87%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 44.75% 45.58% 64.57% 64.54% 70.50% 41.15% 41.12% 41.20%
Other Holding 5.99% 6.17% 4.02% 4.05% 4.06% 5.99% 6.01% 5.93%
Shareholder Count 2,608 2,478 2,499 2,441 2,436 2,115 2,201 2,740

Samsrita Labs Share Dividend Screener - Share Yield Analysis

Check Samsrita Labs dividend history with payout and yield data. View Samsrita Labs dividend details including ex-dates and amounts for SAMSRITA stock.
No dividends declared by Samsrita Labs.

Samsrita Labs Stock Index Membership

See which indices include Samsrita Labs stock. Check SAMSRITA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Samsrita Labs is not part of any tracked indices.
Only major market indices are tracked in our system.

Samsrita Labs Market Events Screener - Corporate Actions

Get Samsrita Labs corporate actions including splits, bonuses, and buybacks. Check Samsrita Labs stock events that may affect SAMSRITA share price.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA 57.70%
2026-02-06 2026-02-06 Quarterly Result Announcement NA 7.85%
2025-10-25 2025-10-25 Quarterly Result Announcement NA 8.11%
2025-08-25 2025-08-25 Annual General Meeting NA 13.66%
2025-07-18 2025-07-18 Quarterly Result Announcement NA -7.67%
2025-05-23 2025-05-23 Extraordinary General Meeting NA -1.25%
2025-04-26 2025-04-26 Quarterly Result Announcement NA 27.43%
2025-01-06 2025-01-06 Quarterly Result Announcement NA -0.04%
2024-11-11 2024-11-11 Quarterly Result Announcement NA -2.06%
2022-08-10 2022-08-10 Change Of Name NA 0.00%

Samsrita Labs Competitors Screener - Peer Comparison

Screen SAMSRITA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Dr. Lal Path Labs 23,332 44.08 2,555 11.28% 492 60.71
Vijaya Diagnostic Centre 10,175 63.10 700 23.06% 144 62.23
Metropolis Healthcare 9,555 57.32 1,346 10.64% 146 58.88
Thyrocare Technologies 6,305 46.76 702 20.80% 91 60.09
Nephrocare Health Services 5,749 78.04 770 33.97% 67 56.24
Krsnaa Diagnostics 1,937 24.10 743 16.70% 78 50.38
Suraksha Diagnostic 1,436 44.50 256 15.11% 31 60.86
One Global Service Provider 1,151 18.72 148 134.60% 19 52.94
3B BlackBio DX 1,038 18.04 112 28.72% 48 44.85
Sastasundar Ventures 860 29.47 1,171 -18.47% -134 43.80

Samsrita Labs Company Announcements - News Screener

Screen SAMSRITA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-04-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-03-28 Closure of Trading Window -
2026-03-11 Strategic Expansion Into The Pet Animal Healthcare And Wellness Segment -
2026-02-07 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-06 Statement Of Deviation Or Variation For The Quarter Ended 31.12.2025 -
2026-02-06 Un-Audited Financial Results For The Quarter And Nine Months Ended 31.12.2025 -
2026-02-06 Board Meeting Outcome for Un-Audited Financial Results (Standalone And Consolidated ) For The Quarter And Nine Months Ended 31.12.2025. -
2026-01-31 Board Meeting Intimation for Board Meeting Intimation For Un-Audited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended 31St December 2025 -
2026-01-06 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-12-29 Closure of Trading Window -
2025-11-24 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2025-11-17 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2025-11-13 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2025-10-27 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2025-10-25 Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended 30Th September 2025 -
2025-10-25 Board Meeting Outcome for Outcome Of Board Meeting Held On 25.10.2025 -
2025-10-21 Board Meeting Intimation for Un-Audited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended 30Th September 2025 -
2025-10-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-09-25 Closure of Trading Window -
2025-09-08 Appointment of Company Secretary and Compliance Officer -